Bristol Myers Fails To Stem The Losses

The loss of $4.3bn in market value yesterday shows how Asco went for Bristol-Myers Squibb (NYSE:BMY) this year - in the minds of investors at least. Despite laying out plans for its next wave of immuno-oncology assets at an event over the weekend, the ...

Source :